Our 3% formulation uses a phospholipid-based delivery system designed to protect the GHK-Cu complex during transit through the lipid-rich outer skin layers and release it at the dermal-epidermal junction
NAD+ has been touted as the next great anti-aging treatment for fighting against age-associated diseases: During human aging, decrease of NAD + levels is associated with potentially reversible dysfunction in the liver, kidney, skeletal and cardiac muscle, endothelial cells, and neurons
This stepwise titration lets you monitor tolerance while gradually reaching the effective dosing levels observed in preclinical research [1] [4]
If the patient needs to transport the medication (e.g., traveling), it should be carried in a cooler bag with ice packs to maintain the cold chain
These reactions typically resolve with continued use as the skin acclimates, or with dose reduction